These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 27264186)

  • 1. Molecular Features Underlying Neurodegeneration Identified through In Vitro Modeling of Genetically Diverse Parkinson's Disease Patients.
    Lin L; Göke J; Cukuroglu E; Dranias MR; VanDongen AM; Stanton LW
    Cell Rep; 2016 Jun; 15(11):2411-26. PubMed ID: 27264186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration of brain region-specific neuronal vulnerability in human iPSC-based model of familial Parkinson's disease.
    Brazdis RM; Alecu JE; Marsch D; Dahms A; Simmnacher K; Lörentz S; Brendler A; Schneider Y; Marxreiter F; Roybon L; Winner B; Xiang W; Prots I
    Hum Mol Genet; 2020 May; 29(7):1180-1191. PubMed ID: 32160287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher vulnerability and stress sensitivity of neuronal precursor cells carrying an alpha-synuclein gene triplication.
    Flierl A; Oliveira LM; Falomir-Lockhart LJ; Mak SK; Hesley J; Soldner F; Arndt-Jovin DJ; Jaenisch R; Langston JW; Jovin TM; Schüle B
    PLoS One; 2014; 9(11):e112413. PubMed ID: 25390032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using Patient-Derived Induced Pluripotent Stem Cells to Identify Parkinson's Disease-Relevant Phenotypes.
    Sison SL; Vermilyea SC; Emborg ME; Ebert AD
    Curr Neurol Neurosci Rep; 2018 Oct; 18(12):84. PubMed ID: 30284665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proneural transcription factor Atoh1 drives highly efficient differentiation of human pluripotent stem cells into dopaminergic neurons.
    Sagal J; Zhan X; Xu J; Tilghman J; Karuppagounder SS; Chen L; Dawson VL; Dawson TM; Laterra J; Ying M
    Stem Cells Transl Med; 2014 Aug; 3(8):888-98. PubMed ID: 24904172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairment of proteasome and anti-oxidative pathways in the induced pluripotent stem cell model for sporadic Parkinson's disease.
    Chang KH; Lee-Chen GJ; Wu YR; Chen YJ; Lin JL; Li M; Chen IC; Lo YS; Wu HC; Chen CM
    Parkinsonism Relat Disord; 2016 Mar; 24():81-8. PubMed ID: 26797011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkin and PINK1 Patient iPSC-Derived Midbrain Dopamine Neurons Exhibit Mitochondrial Dysfunction and α-Synuclein Accumulation.
    Chung SY; Kishinevsky S; Mazzulli JR; Graziotto J; Mrejeru A; Mosharov EV; Puspita L; Valiulahi P; Sulzer D; Milner TA; Taldone T; Krainc D; Studer L; Shim JW
    Stem Cell Reports; 2016 Oct; 7(4):664-677. PubMed ID: 27641647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling Parkinson's Disease Using Patient-specific Induced Pluripotent Stem Cells.
    Li H; Jiang H; Zhang B; Feng J
    J Parkinsons Dis; 2018; 8(4):479-493. PubMed ID: 30149462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival of human induced pluripotent stem cell-derived midbrain dopaminergic neurons in the brain of a primate model of Parkinson's disease.
    Kikuchi T; Morizane A; Doi D; Onoe H; Hayashi T; Kawasaki T; Saiki H; Miyamoto S; Takahashi J
    J Parkinsons Dis; 2011; 1(4):395-412. PubMed ID: 23933658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional comparison of human induced and primary midbrain dopaminergic neurons.
    Xia N; Zhang P; Fang F; Wang Z; Rothstein M; Angulo B; Chiang R; Taylor J; Reijo Pera RA
    Sci Rep; 2016 Feb; 6():20270. PubMed ID: 26842779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial Phenotypes in Parkinson's Diseases-A Focus on Human iPSC-Derived Dopaminergic Neurons.
    Heger LM; Wise RM; Hees JT; Harbauer AB; Burbulla LF
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinacrine and Niclosamide Promote Neurite Growth in Midbrain Dopaminergic Neurons Through the Canonical BMP-Smad Pathway and Protect Against Neurotoxin and α-Synuclein-Induced Neurodegeneration.
    Goulding SR; Lévesque M; Sullivan AM; Collins LM; O'Keeffe GW
    Mol Neurobiol; 2021 Jul; 58(7):3405-3416. PubMed ID: 33713017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological Inhibition of Necroptosis Protects from Dopaminergic Neuronal Cell Death in Parkinson's Disease Models.
    Iannielli A; Bido S; Folladori L; Segnali A; Cancellieri C; Maresca A; Massimino L; Rubio A; Morabito G; Caporali L; Tagliavini F; Musumeci O; Gregato G; Bezard E; Carelli V; Tiranti V; Broccoli V
    Cell Rep; 2018 Feb; 22(8):2066-2079. PubMed ID: 29466734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-Cell Transcriptomics of Parkinson's Disease Human In Vitro Models Reveals Dopamine Neuron-Specific Stress Responses.
    Fernandes HJR; Patikas N; Foskolou S; Field SF; Park JE; Byrne ML; Bassett AR; Metzakopian E
    Cell Rep; 2020 Oct; 33(2):108263. PubMed ID: 33053338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Parkinson's disease-related protein DJ-1 protects dopaminergic neurons in vivo and cultured cells from alpha-synuclein and 6-hydroxydopamine toxicity.
    Batelli S; Invernizzi RW; Negro A; Calcagno E; Rodilossi S; Forloni G; Albani D
    Neurodegener Dis; 2015; 15(1):13-23. PubMed ID: 25500798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of Naivetropic Induced Pluripotent Stem Cells from Parkinson's Disease Patients for High-Efficiency Genetic Manipulation and Disease Modeling.
    Hu Z; Pu J; Jiang H; Zhong P; Qiu J; Li F; Wang X; Zhang B; Yan Z; Feng J
    Stem Cells Dev; 2015 Nov; 24(21):2591-604. PubMed ID: 26218671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stress-induced precocious aging in PD-patient iPSC-derived NSCs may underlie the pathophysiology of Parkinson's disease.
    Zhu L; Sun C; Ren J; Wang G; Ma R; Sun L; Yang D; Gao S; Ning K; Wang Z; Chen X; Chen S; Zhu H; Gao Z; Xu J
    Cell Death Dis; 2019 Feb; 10(2):105. PubMed ID: 30718471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. iPSC-derived dopamine neurons reveal differences between monozygotic twins discordant for Parkinson's disease.
    Woodard CM; Campos BA; Kuo SH; Nirenberg MJ; Nestor MW; Zimmer M; Mosharov EV; Sulzer D; Zhou H; Paull D; Clark L; Schadt EE; Sardi SP; Rubin L; Eggan K; Brock M; Lipnick S; Rao M; Chang S; Li A; Noggle SA
    Cell Rep; 2014 Nov; 9(4):1173-82. PubMed ID: 25456120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SNCA triplication Parkinson's patient's iPSC-derived DA neurons accumulate α-synuclein and are susceptible to oxidative stress.
    Byers B; Cord B; Nguyen HN; Schüle B; Fenno L; Lee PC; Deisseroth K; Langston JW; Pera RR; Palmer TD
    PLoS One; 2011; 6(11):e26159. PubMed ID: 22110584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Parkinson's Disease through Personalized Medicine and Induced Pluripotent Stem Cells.
    Stoddard-Bennett T; Reijo Pera R
    Cells; 2019 Jan; 8(1):. PubMed ID: 30621042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.